Abstract:Human serum albumin (HSA) is a crucial protein in the human body, serving as a carrier for various small molecules and playing a vital role in maintaining osmotic pressure in the bloodstream. However, misfolding and fibrillation of HSA can lead to a range of pathological conditions, including amyloidosis. In recent years, researchers have explored several innovative strategies to inhibit HSA fibrillation, and one of the promising avenues is the utilization of chiral compounds that can offer an effective means of modulating the 'structural integrity of the protein. Among the most prevalent chiral compounds, chiral carbon dots (CCDs) are renowned for their distinctive physicochemical properties, offering unique stereochemical properties, assuming a pivotal role in attaining circularly polarized luminescence that can be harnessed for inhibiting HSA fibrillation. Recent advancement of carbon-based chiral nanostructures has attracted widespread attention in the field of nanobiotechnology owing to their overwhelming chemical, optical and electronic properties. However, being an emerging type of chiral nanomaterial, chiral CDs (CCDs) are still at their primary research stage. Herein, we have developed a simple methodology to quickly synthesize chiral carbon dots ( L / D -TA-C-dots) of size ranging from 3 to 7 nm by microwave-assisted pyrolysis of L / D -tartaric acid, respectively. The circular dichroism spectrum of L / D -TA-C-dots has demonstrated characteristic peaks with opposite nature at around 230–232 nm corresponding to the n → π* transition of CO groups. The synthesized L / D -C-dots have exhibited stable and intense luminescence at 460 nm. A variety of biophysical techniques such as thioflavin-T fluorescence, circular dichroism, fluorescence microscopy, transmission electron microscopy and atomic force microscopy have suggested that the L -TA-C-dots are more effective in hindering the fibrillation process of HSA than D -TA-C-dots. Further, the potential of the synthesized L -TA-C-dots to inhibit the formation of human serum albumin (HSA) fibrils has been investigated in vitro . The biocompatibility of water-soluble L -TA-C-dots has been confirmed by determining the cellular uptake efficiency through a localization study after exposing them to MDA-MB-231 cells. Besides, the thermodynamic parameters for the interaction of HSA monomers with L / D -TA-C-dots have also been calculated, which suggests that the preferential hydrophobic interaction between HSA monomers and L -C-dots restricts the self-assembly of HSA at an early stage, leading to inhibition of fibrillation. The promising results of chiral L -TA-C-dots provide an opportunity to exploit them in the field of in vivo bioimaging and can be used as promising therapeutic agents for various amyloidogenic disorders.

Amyloid Inhibitors: Lysine-Derived Carbon Dots for Chiral Inhibition of Prion Peptide Fibril Assembly (Adv. Therap. 4/2018)

Chiral carbon dots: a smart choice for inhibition of human serum albumin fibrillation

C3N Nanodots Inhibits Aβ Peptides Aggregation Pathogenic Path in Alzheimer's Disease.

Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization

Targeting the Amyloid-β Fibril Surface with a Constrained Helical Peptide Inhibitor.

Amine Group Surface-Functionalized Carbon Quantum Dots Exhibit Anti-amyloidogenic Effects Towards Hen Egg White Lysozyme by Inducing Formation of Nontoxic Spherical Aggregates

Α-Helical Motif As Inhibitors of Toxic Amyloid-β Oligomer Generation Via Highly Specific Recognition of Amyloid Surface

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Cysteine-Derived Chiral Carbon Quantum Dots: A Fibrinolytic Activity Regulator for Plasmin to Target the Human Islet Amyloid Polypeptide for Type 2 Diabetes Mellitus

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation.

Engineering Core/Ligands Interfacial Anchors of Nanoparticles for Efficiently Inhibiting Both Aβ and Amylin Fibrillization

Peptides for Disrupting and Degrading Amyloids.

Chiral effect on Aβ fibrillation from molecular-scale to nanoscale

Novel Chiral Self-Assembled Nano-Fluorescence Materials with AIE Characteristics for Specific Enantioselective Recognition of L-Lysine

Synthesis of aspartic acid-derived chiral carbon dots and their effect on bovine serum albumin amyloid fibrillation by multispectral and molecular interaction studies

Cooperative dissolution of peptidomimetic vesicles and amyloid beta fibrils

Therapeutic Potential for Amyloid Surface Inhibitor: Only Amyloid‐β Oligomers Formed by Secondary Nucleation Disrupt Lipid Membrane Integrity

Rational Design of Nitrogen-Doped Carbon Dots for Inhibiting β-Amyloid Aggregation

Design of amyloidogenic peptide traps

Structure-Based Peptide Inhibitor Design of Amyloid-β Aggregation